Trending Stocks Today | CERo Therapeutics Soars 219.57%
November 11th - US stocks trending in regular trading hours.Gainers: $CERo Therapeutics(CERO.US)$ soars 219.57% to $0.22 with a turnover of $100.75 million. $FOXO Technologies(FOXO.US)$ surges 58.08%
MARA Holdings, RadNet, Bit Digital, Coinbase And Other Big Stocks Moving Higher On Monday
UBS Adjusts Price Target on Affirm to $46 From $41, Maintains Neutral Rating
Is Trending Stock Affirm Holdings, Inc. (AFRM) a Buy Now?
Barclays Maintains Affirm Holdings(AFRM.US) With Buy Rating, Maintains Target Price $54
wells fargo & co raises Affirm's target price to $55.
November 11th by Geruihui | Wells Fargo & Co: Raised the target price of Affirm Holdings from $52 to $55, maintaining a "shareholding" rating. (Geruihui)
Wells Fargo Maintains Overweight on Affirm Holdings, Raises Price Target to $55
Affirm Holdings Options Spot-On: On November 8th, 276.08K Contracts Were Traded, With 651.19K Open Interest
On November 8th ET, $Affirm Holdings(AFRM.US)$ had active options trading, with a total trading volume of 276.08K options for the day, of which put options accounted for 27.27% of the total
Affirm Holdings: Balancing Optimism and Risks in a Volatile Market
Breaking Down Affirm Holdings: 16 Analysts Share Their Views
'Affirm CEO Optimistic On Credit Quality Ahead Of Holiday Season' - Bloomberg News
Affirm Holdings Q1 Loss Narrower-Than-Expected, 2025 GMV View Up
Affirm Holdings Price Target Raised to $57.00/Share From $52.00 by Susquehanna
Affirm Holdings Is Maintained at Positive by Susquehanna
U.S. stock unusual movements | Affirm Holdings (AFRM.US) fell more than 7%, first-quarter losses reduced.
As of the time of publication, the stock has dropped more than 7%, to $45.07.
Affirm Holdings Analyst Ratings
Affirm Stock Falls After 'Drama-Free Quarter.' What We Know. -- Barrons.com
Mizuho Securities Maintains Affirm Holdings(AFRM.US) With Buy Rating
J.P. Morgan Maintains Affirm Holdings(AFRM.US) With Buy Rating, Raises Target Price to $56
SIG Maintains Affirm Holdings(AFRM.US) With Buy Rating, Raises Target Price to $57